Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OCEAN: Formoterol in COPD
NCT00628862Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Dec 2007
- Primary completion
- Apr 2009
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 3 trial of formoterol in chronic obstructive pulmonary disease (COPD), sponsored by AstraZeneca. Started Dec 2007; status: completed.
02
Drugs
formoterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00628862.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00628862.